With Scientific, Operational, and Commercial Acumen GBC Offers Practical Solutions to Turn Expertise and Innovation into Success Neil R. Mucci CEO - GBC Informed, Fast, and Adaptive Approaches to Clinical Research Studies Trial Management, Quality System Management, and Monitoring Services Biospecimen Acquisition and Biorepository Expertise Committed to Shortening Research and Development Timelines and Maximizing Client Value Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine SERVICES OFFERED Consulting Business Trials Biospecimens NEWS OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe ForumOpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 PneumoniaOpGen Wins Chinese NMPA Approval for the Curetis Unyvero SystemEpigenomics AG Plans to Challenge National Coverage Determination (NCD) Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer Screening GBC BLOG Withdrawal of FDA EUA for CDC 2019-Novel Coronavirus RT-PCR Diagnostic PanelWCG Guns for a $100M IPO Amid a Boon in the CRO Sector as it Recovers from COVID ChaosParexel Snapped Up, Again, as Goldman Sachs, EQT Spend $8.5B on the CROChina Embraces Decentralized Clinical Trial Solutions
